Dual Chamber Prefilled Syringes Market Outlook

The global dual chamber prefilled syringes market is projected to grow at a CAGR of 8.7% during the forecast period, 2017 to 2026, according to a new study of Fact.MR.

Roughly US$ 3,300 Mn worth of dual chamber prefilled syringes are likely to be sold across the globe by 2026-end.

Dual chamber prefilled syringes are being widely utilized for storing biological substances or active pharmaceutical components that cannot be stable for extended duration.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=486

Market Taxonomy

Competition Tracking

With trend toward surging adoption of self-injection syringes, and development of technologically advanced dual chamber prefilled syringes, leading players in the market are concentrating on expansion of their product portfolio and the market reach.

In this highly competitive and rapidly evolving market, players are emphasizing on the essentiality of up-to-date information for monitoring their performance and making critical decisions regarding profitability & growth.

Some players in the market are also focusing on making improvements in design of dual chamber prefilled syringes for improving stability and safety of sensitive drugs.

Fact.MR’s report has listed key players augmenting the market expansion, which include

• Bespak Europe Ltd
• Catalent, Inc.
• Credence MedSystems Inc.
• Otsuka America Pharmaceutical Inc.
• Schott AG
• West Pharmaceutical Services Inc.
• Ypsomed Holding AG
• Gerresheimer AG
• Vetter Pharma-Fertigung GmbH & Co. KG
• Nipro Corporation
• Boehringer Ingelheim GmbH
• Amgen Inc.
• Pfizer Inc